An interventional study of Access to the SolanoConnex.org in Mental Health, sponsored by Touro University, California. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-26.
Sponsored by Touro University, California · Not applicable, Interventional, and Supportive care
The goal of this study is to evaluate the effectiveness of the SolanoConnex.org program on help-seeking attitudes and help-seeking behaviors among users compared to a control group. This study will employ a randomized controlled trial design with two parallel arms. Participants in the intervention group will receive full access and orientation to SolanoConnex.org, including multiple features designed to enhance engagement with local mental health resources. Participants in the control group will receive publicly available mental health resources. The primary outcome is any use of mental health services including conversations and communication, digital engagement and media consumption, direct service use or self-help and alternative support all of which will be self-reported through digital diaries prompted every two weeks. Secondary outcomes are endorsed and anticipated Stigma related to mental health, help-seeking attitudes, self-efficacy in seeking mental health care. Potential covariates include demographics, past mental health service use and satisfaction, readiness to change, and discrimination experiences during past healthcare use.
971 studies on the registry are indexed under Psychological Well-Being; 502 are open to participants now.
This study's planned enrollment of 200 is above the median of 116 across 830 interventional studies indexed under Psychological Well-Being.
Browse Psychological Well-Being studies →Touro University, California is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants in the intervention group will be blinded to their study arm status. They will receive full access and orientation to SolanoConnex.org, including multiple features designed to enhance engagement with local mental health resources. First, they will be granted access to the SolanoConnex.org website and mobile application, educational materials, social media and resource navigation. To facilitate ease of use, participants will receive a step-by-step guide and a tutorial video demonstrating how to navigate the platform's features. Additionally, they will gain access to SolanoConnex-produced videos and podcasts which profiles mental health providers and covers various mental health topics.
Behavioral: Access to the SolanoConnex.org
Participants in the control group will also be blinded to their study arm status. They will receive generic materials consisting of access to publicly available mental health resources without exposure to SolanoConnex.org or its patient navigator services. They will be provided with general information on national mental health hotlines, local mental health services, and online directories of available resources but will not receive specific training or guidance in using these resources.
Participants in the intervention group will be blinded to their study arm status. They will receive full access and orientation to SolanoConnex.org, including multiple features designed to enhance engagement with local mental health resources. First, they will be granted access to the SolanoConnex.org website and mobile application, educational materials, social media and resource navigation. To facilitate ease of use, participants will receive a step-by-step guide and a tutorial video demonstrating how to navigate the platform's features. Additionally, they will gain access to SolanoConnex-produced videos and podcasts which profiles mental health providers and covers various mental health topics. To further support participants, patient navigators will be available to provide personalized assistance, helping individuals connect with relevant services. At the outset of the study, participants will receive detailed instructions on how to access and utilize patient navigator support.
Use of any mental health services
Mental health service utilization (i.e. appointment with therapist, attendance at grief group, commencement of PTSD treatment)
Time frame: From enrollment to the end of the 4 month study period
Stigma Related to Mental Health
Endorsed and Anticipated Stigma Inventory (EASI): The EASI is a 40-item self-report inventory that consists of 5 scales assessing mental health beliefs that may be particularly salient for military and Veteran populations, particularly with regard to their willingness to seek mental health treatment. Respondents are asked to rate 8 items in each of 5 scales, 3 that address key aspects of endorsed stigma and 2 that assess key aspects of anticipated stigma. Each scale uses a 5-point Likert-type response format: 1 (strongly disagree), 2 (somewhat disagree), 3 (neither agree nor disagree), 4 (somewhat agree), 5 (strongly agree). Items within each of the 5 scales can be summed to create individual 5 scale scores. The higher the score, the higher the stigma.
Time frame: From enrollment to the end of the 4 month period
Mental Health Help Seeking Attitudes
Mental Help Seeking Attitudes Scale (MHSAS): The MHSAS contains nine items which produce a single mean score. The MHSAS uses a seven-point semantic differential scale. In order to properly calculate the MHSAS mean score, where a higher mean score indicates more favorable attitudes, it is necessary to reverse-code items 2, 5, 6, 8, and 9.
Time frame: From enrollment to the end of the 4 month period
Self-efficacy in seeking Mental Health Care
Self-efficacy in Seeking Mental Health Care Scale: Sum all 9 items. Higher scores indicate greater self-efficacy for seeking mental health care.
Time frame: From enrollment to the end of the 4 month period
Plan to share: Yes — De-identified individual participant data (IPD), including the analyzable dataset underlying published results, may be shared.
Supporting information: Study protocol, Sap, Analytic code
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Touro University, California